Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Roos

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Journal of Alzheimer'S Disease : JAD|April 9, 2019
Geographical Variation in the Diagnostic Rate and Quality of Dementia DiagnosesJohanne Købstrup Zakarias, Christina Jensen-Dahm, Ane Nørgaard, et al.
Frontiers in Aging Neuroscience|September 30, 2021
Cortical Frontoparietal Network Dysfunction in <i>CHMP2B</i>-Frontotemporal DementiaChristian Sandøe Musaeus, Jette Stokholm Pedersen, Troels Wesenberg Kjær, et al.
Dementia and Geriatric Cognitive Disorders|February 24, 2021
Serum Neurofilament Light in Patients with Frontotemporal Dementia Caused by CHMP2B MutationAnders Toft, Peter Roos, Olli Jääskeläinen, et al.
Cerebellum (London, England)|February 13, 2016
SCA28: Novel Mutation in the AFG3L2 Proteolytic Domain Causes a Mild Cerebellar Syndrome with Selective Type-1 Muscle Fiber AtrophyKirsten Svenstrup, Troels Tolstrup Nielsen, Frederik Aidt, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|February 23, 2023
Endo-lysosomal protein concentrations in CSF from patients with frontotemporal dementia caused by <i>CHMP2B</i> mutationAnders Toft, Simon Sjödin, Anja Hviid Simonsen, et al.
Journal of Neuroimmunology|September 9, 2018
Inflammatory markers of CHMP2B-mediated frontotemporal dementiaPeter Roos, Marina Rode von Essen, Troels Tolstrup Nielsen, et al.
Neurobiology of Aging|September 11, 2017
TMEM106B and ApoE polymorphisms in CHMP2B-mediated frontotemporal dementia (FTD-3)Nina Rostgaard, Peter Roos, Esben Budtz-Jørgensen, et al.
Acta Neurologica Scandinavica|January 8, 2022
Six generations of CHMP2B-mediated Frontotemporal Dementia: Clinical features, predictive testing, progression, and survivalPeter Roos, Peter Johannsen, Suzanne G Lindquist, et al.
Translational Psychiatry|November 30, 2019
Cerebrospinal fluid oxidative stress metabolites in patients with bipolar disorder and healthy controls: a longitudinal case-control studyUlla Knorr, Anja Hviid Simonsen, Peter Roos, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Journal of Alzheimer'S Disease : JAD|April 9, 2019
Geographical Variation in the Diagnostic Rate and Quality of Dementia DiagnosesJohanne Købstrup Zakarias, Christina Jensen-Dahm, Ane Nørgaard, et al.
Frontiers in Aging Neuroscience|September 30, 2021
Cortical Frontoparietal Network Dysfunction in <i>CHMP2B</i>-Frontotemporal DementiaChristian Sandøe Musaeus, Jette Stokholm Pedersen, Troels Wesenberg Kjær, et al.
Dementia and Geriatric Cognitive Disorders|February 24, 2021
Serum Neurofilament Light in Patients with Frontotemporal Dementia Caused by CHMP2B MutationAnders Toft, Peter Roos, Olli Jääskeläinen, et al.
Cerebellum (London, England)|February 13, 2016
SCA28: Novel Mutation in the AFG3L2 Proteolytic Domain Causes a Mild Cerebellar Syndrome with Selective Type-1 Muscle Fiber AtrophyKirsten Svenstrup, Troels Tolstrup Nielsen, Frederik Aidt, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|February 23, 2023
Endo-lysosomal protein concentrations in CSF from patients with frontotemporal dementia caused by <i>CHMP2B</i> mutationAnders Toft, Simon Sjödin, Anja Hviid Simonsen, et al.
Journal of Neuroimmunology|September 9, 2018
Inflammatory markers of CHMP2B-mediated frontotemporal dementiaPeter Roos, Marina Rode von Essen, Troels Tolstrup Nielsen, et al.
Neurobiology of Aging|September 11, 2017
TMEM106B and ApoE polymorphisms in CHMP2B-mediated frontotemporal dementia (FTD-3)Nina Rostgaard, Peter Roos, Esben Budtz-Jørgensen, et al.
Acta Neurologica Scandinavica|January 8, 2022
Six generations of CHMP2B-mediated Frontotemporal Dementia: Clinical features, predictive testing, progression, and survivalPeter Roos, Peter Johannsen, Suzanne G Lindquist, et al.
Translational Psychiatry|November 30, 2019
Cerebrospinal fluid oxidative stress metabolites in patients with bipolar disorder and healthy controls: a longitudinal case-control studyUlla Knorr, Anja Hviid Simonsen, Peter Roos, et al.
Pageof 2